Profile
AYTU ZTS TAK HLN TEVA ITCI
Company Name Aytu BioPharma, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $12.34M $73.16B $47.84B $46.83B $19.50B $14.05B
Employees 0.10K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Mr. Joshua R. Disbrow Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
Trading
AYTU ZTS TAK HLN TEVA ITCI
Last Close $2.12 $155.79 $15.06 $10.42 $16.56 $131.87
High 52 $2.92 $196.48 $15.39 $11.41 $22.77 $131.91
Low 52 $1 $144.45 $12.89 $8.26 $12.82 $67.99
Price vs. 52 Week High -27.4 % -20.71 % -2.14 % -8.68 % -27.27 % -0.03 %
Price vs. 52 Week Low 112 % 7.85 % 16.83 % 26.15 % 29.17 % 93.95 %
Total Return
AYTU ZTS TAK HLN TEVA ITCI
1 Month Return 6.8 % -6.29 % 2.52 % -7.3 % -6.57 % 0 %
3 Month Return 70.97 % -5.58 % -0.56 % 2.96 % 6.91 % 0.11 %
6 Month Return 39.47 % -5.35 % 13.49 % 8.09 % -27.27 % 55.42 %
9 Month Return -10.17 % -20.03 % 3.58 % -2.34 % -5.15 % 79.9 %
YTD Return 24.71 % -4.38 % 13.75 % 9.22 % -24.86 % 57.89 %
1 Year Return -25.87 % -11.71 % 16.65 % 23.61 % 1.85 % 85.78 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AYTU ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.13 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) -26.2 % 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) - 32.25 % 280.28 % - - -
Profitability
AYTU ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 68.59 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM 1.32 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM 5.32 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM -7.2 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 92.29 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM -46.08 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM -5.57 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM -297.68 % 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM 1.93 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM 1.81 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM 1.97 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM 4177.61 % 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 55.73 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM -0.9 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM -0.94 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 296.24 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM -7.99 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.82 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM -297.68 % 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM -2.15 32.07 9.73 - 25.68 -191.12
Price To Operating Cash Flows Ratio TTM -2.22 24.98 7.13 - 15.4 -185.85
Price Cash Flow Ratio TTM -2.22 24.98 7.13 - 15.4 -185.85
Income Statement (TTM)
AYTU ZTS TAK HLN TEVA ITCI
Revenue $0.08B $9.26B $4263.76B $11.23B $16.54B $0.68B
Gross Profit $0.05B $6.54B $2832.26B $6.95B $8.06B $0.62B
Gross Profit Ratio 67.39% 70.62% 66.43% 61.85% 48.74% 91.63%
EBITDA $-0B $3.87B $874.6B $2.51B $0.72B $-0.12B
Net Income $-0.02B $2.49B $144.07B $1.44B $-1.64B $-0.07B
EPS Diluted -2.86 5.47 45.58 0.32 -1.45 -0.72
Balance Sheet (MRQ)
AYTU ZTS TAK HLN TEVA ITCI
Long Term Debt $0.01B $5.39B $5029.93B $8.54B $16.3B $0.01B
Total Liabilities $0.09B $9.47B $7834.79B $18.09B $33.61B $0.22B
Total Equity $0.03B $4.77B $7274.01B $16.22B $5.72B $1.15B
Total Investments $-0B $0B $445.7B $0.08B $0B $0.69B
Total Debt $0.02B $6.74B $4843.75B $10.1B $18.08B $0.02B
Total Assets $0.12B $14.24B $15108.79B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
AYTU ZTS TAK HLN TEVA ITCI
Net Income $-0.02B $2.5B $144.07B $1.44B $-1.96B $-0.07B
Inventory $0B $-0.04B $-115.74B $0.22B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-287.19B $-0.57B $0B $0B
Operating Cash Flow $-0B $2.95B $716.34B $2.3B $1.25B $-0.07B
Capital Expenditure $0B $-0.66B $-480.73B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.26
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.45
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.42
ALVOW Alvotech 1.7
AMPH Amphastar Pharmaceuticals, Inc. 23.18
AMRX Amneal Pharmaceuticals, Inc. 8.13
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 65.81
APUS Apimeds Pharmaceuticals US, Inc 1.7183
AQST Aquestive Therapeutics, Inc. 3.25
ASRT Assertio Holdings, Inc. 0.6509
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.29
ETFs With Exposure to AYTU
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00001 133.71
VXF Vanguard Extended Market Index Fund 0 191.37
PQSV PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Value ETF 0.1 66.2468
DFAT Dimensional U.S. Targeted Value ETF 0.00002482 53.82
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000058 35.56
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 145.22
DFSU Dimensional US Sustainability Core 1 ETF 0.00015471 38.88
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 145.23
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0 358.38
Unlock